Growth Metrics

Bruker (BRKR) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Bruker (BRKR) over the last 17 years, with Q3 2025 value amounting to $562.2 million.

  • Bruker's Current Deferred Revenue rose 23.18% to $562.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.2 million, marking a year-over-year increase of 23.18%. This contributed to the annual value of $538.2 million for FY2024, which is 952.38% up from last year.
  • Bruker's Current Deferred Revenue amounted to $562.2 million in Q3 2025, which was up 23.18% from $584.1 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Current Deferred Revenue ranged from a high of $595.8 million in Q2 2024 and a low of $381.2 million during Q3 2023
  • Its 5-year average for Current Deferred Revenue is $479.6 million, with a median of $467.9 million in 2022.
  • As far as peak fluctuations go, Bruker's Current Deferred Revenue skyrocketed by 17698.47% in 2021, and later crashed by 1498.18% in 2023.
  • Bruker's Current Deferred Revenue (Quarter) stood at $430.8 million in 2021, then increased by 9.49% to $471.7 million in 2022, then grew by 4.18% to $491.4 million in 2023, then increased by 9.52% to $538.2 million in 2024, then grew by 4.46% to $562.2 million in 2025.
  • Its last three reported values are $562.2 million in Q3 2025, $584.1 million for Q2 2025, and $575.9 million during Q1 2025.